| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Centre National de la Recherche Scientifique-Unité Mixte de Recherche 5094, Faculté de Pharmacie (N.C., D.B., M.P., J.-C.M., B.P., M.B., S.P.-R.), 34060 Montpellier, France; Institut National de la Recherche Agronomique-Centre National de la Recherche Scientifique-Unité Mixte de Recherche 5087 (T.C.), Saint Christol 30380 Lez Alès, France
Address all correspondence and requests for reprints to: Dr. Sylvie Peraldi-Roux, Faculté de Pharmacie, Centre National de la Recherche Scientifique-UMR 5094, Institut de Biotechnologie et Pharmacologie, 15 avenue Charles Flahault, 34060 Montpellier Cedex 2, France. E-mail address: sylvie.roux{at}ibph.pharma.univ-montp1.fr
Three combinatorial libraries were constructed from unpurified,
CD19+, and antithyroid peroxidase (anti-TPO) B cells
extracted from thyroid tissue of Graves disease patients. Fifteen of
the 41 randomly derived anti-TPO single chain variable region fragments
(scFvs), showed VH13/V
151 or VH169/V
140 heavy/light chain
pairing similar to that obtained with TPO-specific scFv derived from an
in-cell library. One VH13/V
151 scFv, A16, showed exactly the
same nucleotide sequence as in-cell scFv ICB7, demonstrating that
in vivo rearrangement can be obtained from a random
combinatorial library. The majority of the scFvs used a heavy chain
gene derived from the VH13 gene segment, whereas the light chain gene
segments used were more heterogeneous, with dominance of the V
139
and V
151 gene segments. The anti-TPO scFvs showed high affinities
to TPO, with values between 0.77 and 12.3 nM, and defined
seven antigenic regions on the TPO molecule. The anti-TPO fragments,
particularly VH13/V
151 randomly associated scFv B4, which mimic
natural H/L pairing, and VH13/V
140 in-cell-derived scFv ICA5,
efficiently displaced the TPO binding of serum autoantibodies from 20
Graves disease patients. Our study directly demonstrates that
antibodies derived from combinatorial libraries are likely to represent
in vivo pairing, leading to high affinity antibody
fragments mimicking the binding of serum autoantibodies to TPO.
This article has been cited by other articles:
![]() |
S. A. Rebuffat, D. Bresson, B. Nguyen, and S. Peraldi-Roux The key residues in the immunodominant region 353-363 of human thyroid peroxidase were identified Int. Immunol., July 1, 2006; 18(7): 1091 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Latrofa, M. Phillips, B. Rapoport, and S. M. McLachlan Human Monoclonal Thyroglobulin Autoantibodies: Epitopes and Immunoglobulin Genes J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 5116 - 5123. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bresson, M. Cerutti, G. Devauchelle, M. Pugniere, F. Roquet, C. Bes, C. Bossard, T. Chardes, and S. Peraldi-Roux Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases J. Biol. Chem., March 7, 2003; 278(11): 9560 - 9569. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Latrofa, P. Pichurin, J. Guo, B. Rapoport, and S. M. McLachlan Thyroglobulin-Thyroperoxidase Autoantibodies Are Polyreactive, Not Bispecific: Analysis Using Human Monoclonal Autoantibodies J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |